REFINE is a collaboration between 4 European and 2 Australian partners that aims to enhance treatments for mosquito-borne orthoflavivirus infections by identifying new targets for antibodies, inhibitors, and vaccines. In addition, we will develop a platform to test the safety and effectiveness of these treatments before clinical trials.